Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NASAL SOLUTION WITH ANTIVIRAL EFFECT WITH ITS PH VALUE
Document Type and Number:
WIPO Patent Application WO/2022/115069
Kind Code:
A3
Abstract:
The present invention relates to an alkaline-hypertonic, antiviral nasal solution with a pH of 7 and above, characterized in that; it ensures the disruption of the structure of the viruses in the nasal mucosa, as well as the reduction of viral load and related viral replication in its general definition, more specifically it is used in the treatment and prevention of Covid-19 by causing the disruption of the "coronavirus spike glycoprotein E2" structure that binds to the ACE receptors of the coronavirus in the nasal mucosa.

Inventors:
MERTOĞLU HACI MURAT (TR)
YILMAZ YETKIN ZEKI (TR)
Application Number:
PCT/TR2021/050972
Publication Date:
June 30, 2022
Filing Date:
September 22, 2021
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
MERTOGLU HACI MURAT (TR)
International Classes:
A61K9/00; A61K9/08; A61K47/02; A61P31/14
Domestic Patent References:
WO2020112063A12020-06-04
Other References:
ANONYMOUS: "Nasal Irrigation to Reduce COVID-19 Morbidity - Full Text View - ClinicalTrials.gov", 22 September 2020 (2020-09-22), XP055922714, Retrieved from the Internet [retrieved on 20220518]
DANIELLE HARRIS: "Augusta University launches study to test nasal irrigation to treat COVID-19 - Jagwire", 9 October 2020 (2020-10-09), XP055922428, Retrieved from the Internet [retrieved on 20220518]
Attorney, Agent or Firm:
BSE GLOBAL PATENT DANIŞMANLIK DIŞ TİCARET LİMİTED ŞİRKETİ (TR)
Download PDF: